18.02.2013 Views

Timing, hosts and locations of (grouped) events of NanoImpactNet

Timing, hosts and locations of (grouped) events of NanoImpactNet

Timing, hosts and locations of (grouped) events of NanoImpactNet

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

NanoSafetyCluster - Compendium 2012<br />

identity. The capacity to quantitatively track the particles over<br />

long periods <strong>of</strong> time allows us to determine their biological fate,<br />

opening the way for significant advances in our underst<strong>and</strong>ing<br />

<strong>of</strong> the transport pathways used by nanoparticles to access the<br />

brain, using advanced quantitative dosimetrics, selected <strong>and</strong><br />

controlled exposure scenarios, long-lifetime radiolabelled<br />

nanoparticles, <strong>and</strong> biophysical approaches such as fluorescently<br />

labelling certain proteins involved in the transport pathways <strong>and</strong><br />

determining co-localization <strong>of</strong> the proteins <strong>and</strong> nanoparticles.<br />

• deliver the basis for an inventory <strong>of</strong> nanoparticles<br />

based on potential for exposure, categorising nanoparticles on<br />

the basis <strong>of</strong> physicochemical, structural <strong>and</strong> toxicological<br />

properties:<br />

As above, the capacity to categorise nanoparticles based on<br />

their biological identity will <strong>of</strong>fer key advances in our predictive<br />

skills, <strong>and</strong> enable us to connect high throughput screening data<br />

to a screening predictive phenomenological models.<br />

• establish relations between experimental (based on<br />

available data) <strong>and</strong> computational properties:<br />

6 References<br />

1. Cedervall, T., Lynch, I., Lindman, S., Nilsson, H., Thulin, E.,<br />

Linse, S., Dawson K.A. PNAS 2007, 104, 2050-2055.<br />

2. Cedervall, T., Lynch, I., Foy, M., Berggård, T., Donnelly, S.C.,<br />

Cagney, G., Linse, S., Dawson, K.A. . Angew. Chem. Int. Ed. 2007,<br />

46, 5754 -5756.<br />

3. Lundqvist, M., Stigler, J., Cedervall, T., Elia, G., Lynch, I.,<br />

Dawson, K.A. PNAS 2008, 105, 14265-14270.<br />

7 Directory<br />

Table 1 Directory <strong>of</strong> people involved in the NanoTransKinetics project as beneficiaries*.<br />

Data from several successful EU FP6 <strong>and</strong> FP7 projects is being<br />

used as the basis for the project (the minimum set <strong>of</strong><br />

experimental data is already under our control via the<br />

NanoInteract, NeuroNano <strong>and</strong> BioNanoInteract projects which<br />

were coordinated by P1, <strong>and</strong> additional data will be acquired,<br />

assessed <strong>and</strong> implemented via WP5, the NanoSafety cluster <strong>and</strong><br />

the twinned US projects). As the modelling approaches<br />

described are phenomenological initially, they rely directly on<br />

the experimental data, in order to reproduce the phenomena,<br />

such as protein corona formation, nanoparticles uptake <strong>and</strong> subcellular<br />

transport <strong>and</strong> localisation) <strong>and</strong> we see a key outcome <strong>of</strong><br />

the project as being a set <strong>of</strong> modelling tools that can be linked<br />

directly to High Content Analysis assays, such as lysosomal load,<br />

in order to correlate impacts with sub-cellular localisation <strong>and</strong><br />

bioaccumulation potential, for example. We believe that the<br />

approach outlined here is the only realistic possibility for<br />

underst<strong>and</strong>ing <strong>and</strong> predicting the implications <strong>of</strong> nanoparticles<br />

for living systems, as it is based on underst<strong>and</strong>ing the<br />

mechanisms <strong>of</strong> interaction <strong>of</strong> nanoparticles with cells.<br />

4. Walczyk, D., Baldelli-Bombelli, F., Campbell, A., Lynch, I.,<br />

Dawson, K.A. J. Am. Chem. Soc. 2010, 132, 5761-5768.<br />

5. Salvati, A.; dos Santos, T.; Varela, J.; Pinto, P.; Lynch, I.;<br />

Dawson, K.A., NanoMedicine, 2011, in press.<br />

6. Shapero, K., Fenaroli, F., Lynch, I., Cottell, D.C., Salvati, A.,<br />

Dawson, K.A. Time <strong>and</strong> space resolved uptake study <strong>of</strong> silica<br />

nanoparticles by human cells. Mol Biosyst. 2010 Sep 29. [Epub<br />

ahead <strong>of</strong> print]<br />

7. Watson, P. J., A.T., Stephens, D.J. Adv. Drug Del. Rev. 2005,<br />

57, 43- 61.<br />

First Name Last Name Affiliation Address e-mail<br />

Vicki Colvin Rice University Houston<br />

TX 77005-1827<br />

USA<br />

Kenneth Dawson National University <strong>of</strong> Irel<strong>and</strong>, Dublin /<br />

University College Dublin<br />

Belfield<br />

IE-4 Dublin<br />

Irel<strong>and</strong><br />

Giancarlo Franzese University <strong>of</strong> Barcelona Av. Diagonal 647<br />

Barcelona 08028<br />

Spain<br />

Iseult Lynch National University <strong>of</strong> Irel<strong>and</strong>, Dublin /<br />

University College Dublin<br />

Aine Moore National University <strong>of</strong> Irel<strong>and</strong>, Dublin /<br />

University College Dublin<br />

Belfield<br />

IE-4 Dublin<br />

Irel<strong>and</strong><br />

Belfield<br />

IE-4 Dublin<br />

Irel<strong>and</strong><br />

Joachim Rädler Ludwig-Maximilians University Geschwister-Scholl-<br />

Platz 1<br />

Munich 80539<br />

Germany<br />

colvin@rice.edu<br />

kenneth.a.dawson@cbni.ucd.ie<br />

gfranzese@ub.edu<br />

iseult.lynch@cbni.ucd.ie<br />

aine.moore@cbni.ucd.ie<br />

joachim.raedler@lmu.de<br />

202 Compendium <strong>of</strong> Projects in the European NanoSafety Cluster

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!